Search

everythinglearnresearchcommunity

for

Search:↓

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Finasteride may reduce bleeding after TURP, but more research needed.

Ashwagandha serum improves hair health and quality of life in people with hair loss.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Men with hair loss may lack zinc, copper, and vitamin D; supplements could help.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Finasteride boosts stem cell signals for hair growth.

Finasteride helps reduce lung inflammation and damage after trauma and infection.

Finasteride improves immune response and reduces organ damage after trauma hemorrhage in mice.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.